Abstract
Th2 cytokines are associated with the airway inflammation and hyperreactivity in allergic asthma and are potential targets for developing novel therapies. The efficacy of a mucosal cytokine-gene transfer approach was examined in a mouse model for allergic asthma. We showed first that mucosal IFN-γ gene transfer results in a significant expression of IFN-γ in the pulmonary epithelium. Significantly, this approach inhibits both Ag- and Th2-cell-induced pulmonary eosinophilia and airway hyperreactivity. These findings suggest that mucosal IFN-γ gene transfer is effective in modulating pulmonary allergic responses and provides a basis for developing a novel therapeutic approach.
| Original language | English |
|---|---|
| Pages (from-to) | 3216-3219 |
| Number of pages | 4 |
| Journal | Journal of Immunology |
| Volume | 157 |
| Issue number | 8 |
| State | Published - 15 Oct 1996 |
| Externally published | Yes |